PEA drug
Evidence from:
primary |
all sources
Related entities (15)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| FAAH | regulates | PEA | — | 1 |
| PEA | associated_with | amygdala | — | 1 |
| PEA | associated_with | attention network | — | 1 |
| PEA | associated_with | balance | — | 1 |
| PEA | associated_with | basal ganglia | — | 1 |
| PEA | associated_with | caudate nucleus | — | 1 |
| PEA | associated_with | cerebellum | — | 1 |
| PEA | associated_with | coordination | — | 1 |
| PEA | associated_with | corpus callosum | — | 1 |
| PEA | risk_factor_for | corpus callosum | — | 1 |
| PEA | associated_with | hippocampus | — | 1 |
| PEA | interacts_with | PPARA | — | 1 |
| PEA | protective_against | Reinforcing properties of nicotine | — | 1 |
| PEA | associated_with | thalamus | — | 1 |
| URB597 | regulates | PEA | — | 1 |
Mentioned in (5)
Papers in which this entity is mentioned.
- Cannabinoid receptor 1 signaling in embryo neurodevelopment. (2012)
- Focus on: structural and functional brain abnormalities in fetal alcohol spectrum disorders. (2011)
- Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. (2011)
- Neuroimaging of children following prenatal drug exposure. (2009)
- Neuroimaging of children following prenatal drug exposure. (2009)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| pea | drug | 5 | 8 |
| palmitoylethanolamide | drug | 1 | 1 |